LGD-4033 10mg is a SARM oral tablet formulation supplied in 3 x 15 blister packs (45 tablets total). Manufactured for consistency, stability, and research applications.
Format45 Tablets
Concentration10mg
Pay with Interac e-Transfer or Crypto
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
LGD-4033, commonly known as Ligandrol, is one of the most extensively researched selective androgen receptor modulators (SARMs) in clinical and preclinical literature, having progressed through Phase I and Phase II human clinical trials examining muscle wasting and sarcopenia indications, contributing one of the more substantial human research datasets of any SARM compound. This formulation delivers 10mg per tablet across three 15 tablet blister packs, supplying 45 tablets total in a segmented packaging format that protects unused tablets from environmental exposure compared to bottle based packaging.
SARMs as a compound class are defined by their tissue selective androgen receptor activation, unlike testosterone and other anabolic steroids that activate androgen receptors broadly across skeletal muscle, bone, prostate, and other androgen sensitive tissue, SARMs are designed to preferentially activate androgen receptors in muscle and bone tissue while exerting minimal activity in androgenic tissue like the prostate and scalp. LGD-4033 demonstrates this selective activation profile through its non steroidal chemical structure, which binds the androgen receptor with high affinity while avoiding the 5-alpha reductase and aromatase enzyme interactions that produce androgenic and estrogenic side effects with traditional anabolic steroids. This selectivity has made LGD-4033 one of the most studied compounds in research examining tissue selective androgen receptor pharmacology.
LGD-4033’s clinical trial data has documented dose dependent increases in lean body mass alongside measurable suppression of endogenous testosterone, SHBG, and HDL cholesterol at higher research doses. Findings that have positioned it as a frequently referenced compound in comparative SARM research examining the relationship between anabolic efficacy and HPG axis suppression across different SARM structural classes. Its relatively long half-life of approximately 24–36 hours supports once daily research administration, distinguishing its pharmacokinetic profile from shorter acting SARM compounds requiring more frequent dosing.
This generic formulation is stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s SARM range covers multiple compounds across the tissue selective androgen receptor modulator class for comprehensive comparative research sourcing from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Store in a cool, dry place away from direct light and heat. Intended for research purposes only.
Commonly researched alongside other SARM compounds and PCT agents in comparative androgen receptor selectivity studies. Browse CSD’s full SARM range for complete sourcing.
I started using this product just a few days ago. I wasn’t familiar with this category of molecules before, but after reading up on the subject, I’m convinced it adds significant value to any cycle. The price is definitely the best on the market, paired with undeniable quality. Highly recommended!
